High fragmentation characterizes tumour-derived circulating DNA
- PMID: 21909401
- PMCID: PMC3167805
- DOI: 10.1371/journal.pone.0023418
High fragmentation characterizes tumour-derived circulating DNA
Abstract
Background: Circulating DNA (ctDNA) is acknowledged as a potential diagnostic tool for various cancers including colorectal cancer, especially when considering the detection of mutations. Certainly due to lack of normalization of the experimental conditions, previous reports present many discrepancies and contradictory data on the analysis of the concentration of total ctDNA and on the proportion of tumour-derived ctDNA fragments.
Methodology: In order to rigorously analyse ctDNA, we thoroughly investigated ctDNA size distribution. We used a highly specific Q-PCR assay and athymic nude mice xenografted with SW620 or HT29 human colon cancer cells, and we correlated our results by examining plasma from metastatic CRC patients.
Conclusion/significance: Fragmentation and concentration of tumour-derived ctDNA is positively correlated with tumour weight. CtDNA quantification by Q-PCR depends on the amplified target length and is optimal for 60-100 bp fragments. Q-PCR analysis of plasma samples from xenografted mice and cancer patients showed that tumour-derived ctDNA exhibits a specific amount profile based on ctDNA size and significant higher ctDNA fragmentation. Metastatic colorectal patients (n = 12) showed nearly 5-fold higher mean ctDNA fragmentation than healthy individuals (n = 16).
Conflict of interest statement
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3167805/bin/pone.0023418.g001.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3167805/bin/pone.0023418.g002.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3167805/bin/pone.0023418.g003.gif)
![Figure 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3167805/bin/pone.0023418.g004.gif)
![Figure 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3167805/bin/pone.0023418.g005.gif)
![Figure 6](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3167805/bin/pone.0023418.g006.gif)
![Figure 7](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3167805/bin/pone.0023418.g007.gif)
Similar articles
-
Origin and quantification of circulating DNA in mice with human colorectal cancer xenografts.Nucleic Acids Res. 2010 Oct;38(18):6159-75. doi: 10.1093/nar/gkq421. Epub 2010 May 21. Nucleic Acids Res. 2010. PMID: 20494973 Free PMC article.
-
Individualized Mutation Detection in Circulating Tumor DNA for Monitoring Colorectal Tumor Burden Using a Cancer-Associated Gene Sequencing Panel.PLoS One. 2016 Jan 4;11(1):e0146275. doi: 10.1371/journal.pone.0146275. eCollection 2016. PLoS One. 2016. PMID: 26727500 Free PMC article. Clinical Trial.
-
Multi-marker analysis of circulating cell-free DNA toward personalized medicine for colorectal cancer.Mol Oncol. 2014 Jul;8(5):927-41. doi: 10.1016/j.molonc.2014.02.005. Epub 2014 Mar 24. Mol Oncol. 2014. PMID: 24698732 Free PMC article.
-
The importance of examining the proportion of circulating DNA originating from tumor, microenvironment and normal cells in colorectal cancer patients.Expert Opin Biol Ther. 2012 Jun;12 Suppl 1:S209-15. doi: 10.1517/14712598.2012.688023. Epub 2012 May 18. Expert Opin Biol Ther. 2012. PMID: 22594497 Review.
-
[Liquid biopsy in colorectal cancer : An overview of ctDNA analysis in tumour diagnostics].Pathologe. 2019 Dec;40(Suppl 3):244-251. doi: 10.1007/s00292-019-00698-3. Pathologe. 2019. PMID: 31797045 Review. German.
Cited by
-
DNA methylation and gene expression as determinants of genome-wide cell-free DNA fragmentation.Nat Commun. 2024 Aug 6;15(1):6690. doi: 10.1038/s41467-024-50850-8. Nat Commun. 2024. PMID: 39107309 Free PMC article.
-
Translation of Epigenetics in Cell-Free DNA Liquid Biopsy Technology and Precision Oncology.Curr Issues Mol Biol. 2024 Jun 27;46(7):6533-6565. doi: 10.3390/cimb46070390. Curr Issues Mol Biol. 2024. PMID: 39057032 Free PMC article. Review.
-
Systematically Evaluating Cell-Free DNA Fragmentation Patterns for Cancer Diagnosis and Enhanced Cancer Detection via Integrating Multiple Fragmentation Patterns.Adv Sci (Weinh). 2024 Aug;11(30):e2308243. doi: 10.1002/advs.202308243. Epub 2024 Jun 17. Adv Sci (Weinh). 2024. PMID: 38881520 Free PMC article.
-
On-Chip Magnetic Extraction of Circulating Cell-Free DNA from Biological Samples.Methods Mol Biol. 2024;2804:65-75. doi: 10.1007/978-1-0716-3850-7_3. Methods Mol Biol. 2024. PMID: 38753140
-
Association of the immediate perioperative dynamics of circulating DNA levels and neutrophil extracellular traps formation in cancer patients.Precis Clin Med. 2024 Mar 27;7(2):pbae008. doi: 10.1093/pcmedi/pbae008. eCollection 2024 Jun. Precis Clin Med. 2024. PMID: 38699382 Free PMC article.
References
-
- Sawyers CL. The cancer biomarker problem. Nature. 2008;452:548–552. - PubMed
-
- Gormally E, Hainaut P, Caboux E, Airoldi L, Autrup H, et al. Amount of DNA in plasma and cancer risk: a prospective study. Int J Cancer. 2004;111:746–749. - PubMed
-
- Fleischhacker M, Schmidt B. Circulating nucleic acids (CNAs) and cancer—a survey. Biochim Biophys Acta. 2007;1775:181–232. - PubMed
-
- Frattini M, Gallino G, Signoroni S, Balestra D, Lusa L, et al. Quantitative and qualitative characterization of plasma DNA identifies primary and recurrent colorectal cancer. Cancer Lett. 2008;263:170–181. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical